PN,31901
SC,0001
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FA new three-drug combination could
OL,8,Fhelp women with a common form of
OL,9,Faggressive breast cancer live longer,
OL,10,Fresearch suggests.
OL,12,FThe treatment could also delay the
OL,13,Fneed for gruelling chemotherapy,
OL,14,Faccording to a trial.
OL,16,FIf approved by the NHS, it could help
OL,17,Fthousands of patients every year.
OL,1,W~k4~sj5j5~s1G                    G1/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31902
SC,0002
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FResearchers are hopeful the
OL,8,Fcombination could become the "new go-
OL,9,Fto option" for women with PIK3CA-
OL,10,Fmutated hormone receptor-positive
OL,11,F(HR+) human epidermal growth factor
OL,12,Freceptor 2 negative (HER2-) breast
OL,13,Fcancer.
OL,15,FThis mutation in the PIK3CA gene
OL,16,Fcauses cells to divide and replicate
OL,17,Funcontrollably.
OL,26,@pD@^OUqD@JO]
OL,1,W~k4~sj5j5~s1G                    G2/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31903
SC,0003
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FThe final results from the INAVO120
OL,8,Fstudy, led by experts at The Institute
OL,9,Fof Cancer Research, London, and the
OL,10,FRoyal Marsden NHS Foundation Trust,
OL,11,Fhave been published in the New England
OL,12,FJournal of Medicine and presented at
OL,13,Fthe American Society of Clinical
OL,14,FOncology (ASCO) annual meeting in
OL,15,FChicago.
OL,1,W~k4~sj5j5~s1G                    G3/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31904
SC,0004
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FProfessor Nick Turner said: "These
OL,8,Fresults give us confidence that this
OL,9,Ftreatment could become the new go-to
OL,10,Foption for patients who have HR+, HER2-
OL,11,F breast cancer with a PIK3CA mutation,
OL,12,Fas it has shown significant
OL,13,Fimprovements in both survival and
OL,14,Fquality of life."
OL,16,FThe trial included 325 patients from
OL,17,Facross 28 countries.
OL,1,W~k4~sj5j5~s1G                    G4/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31905
SC,0005
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FMore than half had metastatic breast
OL,8,Fcancer that had spread to three or
OL,9,Fmore organs, and the majority had
OL,10,Falready had chemotherapy.
OL,12,FWhat is the three-drug therapy?
OL,14,FResearchers used a blood test known as
OL,15,Fa liquid biopsy, which detects tumour
OL,16,FDNA in the blood, to test for the
OL,17,FPIK3CA mutation.
OL,1,W~k4~sj5j5~s1G                    G5/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31906
SC,0006
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FOf the total, 161 were given a three-
OL,8,Fdrug combination comprising two
OL,9,Ftargeted drugs ` palbociclib, a type
OL,10,Fof cancer growth blocker, and a new
OL,11,Fdrug called inavolisib, which blocks
OL,12,Fthe activity of the PI3K protein ` as
OL,13,Fwell as the hormone therapy
OL,14,Ffulvestrant.
OL,16,FThe placebo group, which included 164
OL,17,Fpatients, was given a dummy pill plus
OL,18,Fpalbociclib and fulvestrant.
OL,1,W~k4~sj5j5~s1G                    G6/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31907
SC,0007
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FThe study found the median overall
OL,8,Fsurvival in the inavolisib group was
OL,9,F34 months, compared with 27 months in
OL,10,Fthe placebo group.
OL,12,FThe three-drug therapy also delayed
OL,13,Fdisease progression by 17.2 months,
OL,14,Fcompared with 7.3 months in the
OL,15,Fplacebo group, with patients also able
OL,16,Fto delay chemotherapy treatment by
OL,17,Falmost two years longer.
OL,1,W~k4~sj5j5~s1G                    G7/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31908
SC,0008
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FThe latest results come after previous
OL,8,Fanalysis of the study, published in
OL,9,FOctober, showed the three-drug therapy
OL,10,Fdelayed disease progression by an
OL,11,Faverage of 15 months compared with 7.3
OL,12,Fmonths in the placebo group.
OL,1,W~k4~sj5j5~s1G                    G8/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31909
SC,0009
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FLead author Nick Turner, a professor
OL,8,Fof molecular oncology at The Institute
OL,9,Fof Cancer Research, London, and
OL,10,Fconsultant medical oncologist at The
OL,11,FRoyal Marsden NHS Foundation Trust,
OL,12,Fsaid: "The key findings from this
OL,13,Fstudy showed that the inavolisib-based
OL,14,Ftherapy not only helped patients live
OL,15,Flonger but it more than doubled the
OL,16,Ftime before their cancer progressed or
OL,17,Fworsened.
OL,26,@tD@GOU
OL,1,W~k4~sj5j5~s1G                    G9/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31910
SC,0010
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,F"It also gave them more time before
OL,8,Fneeding subsequent chemotherapy, which
OL,9,Fwe know is something that patients
OL,10,Freally fear and want to delay for as
OL,11,Flong as possible.
OL,13,F"These results give us confidence that
OL,14,Fthis treatment could become the new go-
OL,15,Fto option for patients who have HR+,
OL,16,FHER2- breast cancer with a PIK3CA
OL,17,Fmutation, as it has shown significant
OL,18,Fimprovements in both survival and
OL,19,Fquality of life."
OL,21,FHow many women could this help?
OL,26,@oD@AOUuD@AOU{D@QO]
OL,1,W~k4~sj5j5~s1G                   G10/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31911
SC,0011
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FIt is estimated that about 55,000
OL,8,Fwomen are diagnosed with breast cancer
OL,9,Fin the UK every year, some 70% of whom
OL,10,Fwill have HR+, HER2- breast cancer.
OL,12,FPIK3CA mutations are found in 35-40%
OL,13,Fof HR+ breast cancers.
OL,15,FThe three-drug therapy of inavolisib,
OL,16,Fpalbociclib and fulvestrant is not
OL,17,Fapproved in the UK.
OL,1,W~k4~sj5j5~s1G                   G11/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31912
SC,0012
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FHowever, the combination of
OL,8,Fpalbociclib and fulvestrant has been
OL,9,Favailable as an option for patients
OL,10,Fwith certain types of breast cancer on
OL,11,Fthe NHS since 2022.
OL,13,FProfessor Kristian Helin, chief
OL,14,Fexecutive of The Institute of Cancer
OL,15,FResearch, London, said: "This research
OL,16,Fdemonstrates how this triple
OL,17,Fcombination approach effectively shuts
OL,18,Fdown cancer's escape routes, giving
OL,19,Fpeople with metastatic breast cancer
OL,20,Fthe opportunity to live well for
OL,21,Flonger.
OL,1,W~k4~sj5j5~s1G                   G12/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31913
SC,0013
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,FHe added: "If we are to continue
OL,8,Fimproving cancer survival rates, we
OL,9,Fneed to tackle treatment resistance
OL,10,Fhead on.
OL,12,F"This research demonstrates how this
OL,13,Ftriple combination approach
OL,14,Feffectively shuts down cancer's escape
OL,15,Froutes, giving people with metastatic
OL,16,Fbreast cancer the opportunity to live
OL,17,Fwell for longer.
OL,26,@oD@KOUtD@AOU
OL,1,W~k4~sj5j5~s1G                   G13/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
PN,31914
SC,0014
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F319A1748818908
OL,3,CThree-drug therapy could help women
OL,4,Cwith aggressive breast cancer live
OL,5,Clonger
OL,7,F"One of the challenges with
OL,8,Fcombination therapies is ensuring the
OL,9,Fright drug dosages and understanding
OL,10,Ftheir individual effects.
OL,12,F"It is extremely encouraging that this
OL,13,Fstudy not only demonstrates the
OL,14,Feffectiveness of this approach but
OL,15,Falso shows that the therapy was
OL,16,Fgenerally well tolerated by patients."
OL,26,@oD@AOUtD@AOUxD@fO]
OL,1,W~k4~sj5j5~s1G                   G14/14
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,350,300,200,140,000,100
